BENFO-TEAM

Purpose

The BenfoTeam Study is a multi-site clinical trial evaluating whether Benfotiamine, a form of vitamin B1, can help slow memory decline and support brain health in individuals with early Alzheimer's disease. Benfotiamine is thought to enhance brain energy metabolism and reduce biological changes linked to Alzheimer's, including inflammation and abnormal protein buildup. Early research has shown it to be safe, well-tolerated, and potentially beneficial for cognition and daily function.

Keywords: Mild Cognitive Impairment (MCI), early AD, dementia, memory concerns

Study Sites

1520 San Pablo St. Suite 3000 Los Angeles, CA 90033

 
  • Men & Women
Age icon
50 - 89
 
 
To find out if you are eligible for the study contact Carlota Conant at adrc@med.usc.edu or (323) 442-7600. 
 

Why participate?

Medical advances are impossible without volunteers.

Eligibility

Must have

  • You are between 50 and 89 years old
  • You have been diagnosed with Mild Cognitive Impairment (MCI) or early Alzheimer's disease
  • You've noticed changes in memory or thinking, or your family and friends have observed that you seem more forgetful or less sharp than before
  • You have a study partner or caregiver who knows you well and can accompany you to study visits
  • You have been taking your usual medications at stable doses for at least 4 weeks before joining
  • You are willing and able to attend regular study visits and participate in study activities

Can't have

    There are no exclusion criteria

Study Website

https://www.benfoteam.org/ 

Study Team

Photohandler
Principal Investigator
Lon Schneider, MD

For questions about this study, contact:

We respect your privacy!

All the information you give us is stored in a secure, password protected database. All the information that you choose to share will be kept private and confidential. Read University of Southern California's Privacy Policy here.